SU2C is making $7.5 million in research grants available to early-career scientists who are pursuing innovative cancer research projects focusing on immuno-oncology, the American Association for Cancer Research said. Funded by a grant Bristol-Myers Squibb Co. a total of 10 Innovative Research Grants will be available, each up to $750,000, over three years. The IRG...
More than a year after a catastrophic shortage of platinum-based chemotherapy drugs swept through the U.S., FDA on June 28 officially removed carboplatin and cisplatin from the drug shortage list.
